$47B
Addressable market
5,200 elite clinics
€112k
ARR per clinic
24-clinic founding cohort
Non-SaMD
Data in Europe
GDPR · sovereign cloud
Pre-seed
Current round
path to Series A
00Executive BriefTHE COMPANY · PRODUCT · TEAM · THE RAISE
OPEN
01Investment Thesis & Strategic FitSANABIL MANDATE · VISION 2030 · STAGED ENTRY
OPEN
02Market & OpportunityTAM · VERTICALS · COMPETITIVE LANDSCAPE
OPEN
03Roadmap & Use of ProceedsSAS · NON-DILUTIVE · COHORT · ACCELERATOR · SERIES A
OPEN
04Financial Projections5-YEAR MODEL · ILLUSTRATIVE & FORWARD-LOOKING
OPEN
—Financial ModelEDITABLE EXCEL · ASSUMPTIONS · USE OF PROCEEDS
EXCEL
05Product & TechnologyCAPABILITIES · AI ENGINE · SECURITY & GDPR
OPEN
06Traction & PipelineINTRODUCER NETWORK · FOUNDING COHORT · PIPELINE
OPEN
07Corporate, Legal & Cap TableRCS · TRADEMARK · IP · 100% FOUNDER-OWNED
OPEN